Shares of Moderna dropped 5.22% to $146.98 at 15:30 EST on Tuesday, following yesterday’s downward trend. The Nasdaq Stock Market is rising 1.01% to $12,566.20, following yesterday’s upward trend, This seems, at the moment, an all-around positive trend exchanging session today.

Moderna’s last close was $155.07, 21.45% below its 52-week high of $178.50.

News about Moderna today

Take-two, occidental petroleum, Moderna: what to watch when the stock market opens today. According to today’s article on The Wall Street Journal, "-Shares of the vaccine maker Moderna were down 1% premarket. "

Moderna vaccine found safe, effective ahead of key FDA review. According to today’s article on Bloomberg Quint, "The FDA got a much deeper look at Moderna’s clinical-trial data than the numbers previously released to the public by the company. ", "Moderna’s vaccine will be distributed to sites around the country where health-care workers and residents of long-term care facilities, such as nursing homes, are expected to get the earliest doses."

Moderna vaccine found safe, effective before key FDA review. According to today’s article on Bloomberg Quint, "Both the Moderna Pfizer products are based on messenger RNA technology that hasn’t been previously used in human vaccines. ", "Moderna’s vaccine isn’t yet approved in any other countries and hasn’t yet been used on anyone outside of a clinical trial."

Moderna shares up in premarket as FDA calls Covid-19 vaccine 'highly effective'. According to today’s article on MarketWatch, "Shares of Moderna Inc. gained 1.5% in premarket trading on Tuesday after the Food and Drug Administration said the company’s COVID-19 vaccine candidate is “highly effective” at preventing infections with the coronavirus. "

Canada to receive early access to Moderna Covid-19 vaccine. According to today’s article on Business Insider, "Today, the Honourable Anita Anand, Minister of Public Services and Procurement, announced that following successful negotiations and contingent on Health Canada authorization of the vaccine, Canada will be able to access 168,000 doses of the Moderna COVID-19 vaccine in December 2020.", "These are part of the guaranteed 40 million doses, and up to a total of 56 million doses, that Canada has secured through its existing agreement with Moderna. "

Moderna’s Sales

Moderna’s sales growth is 1428.1% for the present quarter and 13065.3% for the next. The company’s growth estimates for the current quarter is a negative 48.6% and positive 565.7% for the next.

Moderna’s Revenue

Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months.

Moderna’s Stock Top and Bottom Yearly Value

Moderna’s stock is valued at $146.98 at 15:30 EST, way below its 52-week high of $178.50 and way above its 52-week low of $17.68.

Moderna’s Moving Average

Moderna’s value is way above its 50-day moving average of $106.15 and way above its 200-day moving average of $77.98.

Previous days news about Moderna

Moderna offers U.S. fail-safe on vaccines if Pfizer falls short. According to Bloomberg Quint on Thu Dec 10, "If the U.S. doesn’t lock in the full 400 million extra doses, it could free up capacity for Moderna to sell more supply to other countries, potentially at a higher price.", "Moderna has said it expects to produce 500 million to 1 billion total doses of its vaccine in 2021. "

Moderna says U.S. to buy 100 million additional vaccine doses. According to Bloomberg Quint on Fri Dec 11, "Moderna has said it expects to produce 500 million to 1 billion total doses of its vaccine in 2021. ", "As part of Operation Warp Speed, the U.S. initiative to rapidly develop and secure vaccines for Covid-19, the U.S. has the option to buy another 300 million doses from Moderna at a fixed price of $16.50 per shot, the company said. "

LEAVE A REPLY

Please enter your comment!
Please enter your name here